Welcome to the SWSLHD Libraries Research Repository, an institutional repository which showcases the research output of South Western Sydney Local Health District staff, both past and present. The repository supports the SWSLHD Strategic Plan in their vision for the SWSLHD to be a leader in research and innovation.
Please use this identifier to cite or link to this item:
https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13060Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yeung, D. T. | - |
| dc.contributor.author | Shanmuganathan, N. | - |
| dc.contributor.author | Reynolds, J. | - |
| dc.contributor.author | Branford, S. | - |
| dc.contributor.author | Walia, M. | - |
| dc.contributor.author | Yong, A. S. M. | - |
| dc.contributor.author | Shortt, J. | - |
| dc.contributor.author | Chee, L. | - |
| dc.contributor.author | Viiala, N. | - |
| dc.contributor.author | Cunningham, I. | - |
| dc.contributor.author | Ross, D. M. | - |
| dc.contributor.author | D'Souza, A. | - |
| dc.contributor.author | Wright, M. | - |
| dc.contributor.author | Harrup, R. | - |
| dc.contributor.author | Forsyth, C. | - |
| dc.contributor.author | Filshie, R. | - |
| dc.contributor.author | Lane, S. | - |
| dc.contributor.author | Browett, P. | - |
| dc.contributor.author | Grove, C. | - |
| dc.contributor.author | Grigg, A. P. | - |
| dc.contributor.author | Hughes, T. P. | - |
| dc.contributor.author | Viiala, N. | - |
| dc.date.accessioned | 2024-12-11T00:33:26Z | - |
| dc.date.available | 2024-12-11T00:33:26Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.issn | 00064971 (ISSN) | - |
| dc.identifier.uri | https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13060 | - |
| dc.description.abstract | Asciminib is a myristoyl site BCR | - |
| dc.publisher | Elsevier B.V. | - |
| dc.subject | Adult Aged Aged, 80 and over Antineoplastic Agents Female Follow-Up Studies Fusion Proteins, bcr-abl Humans Imatinib Mesylate Leukemia, Myeloid, Chronic-Phase Male Middle Aged Niacinamide Protein Kinase Inhibitors Pyrazoles Pyrimidines Treatment Outcome Young Adult alanine aminotransferase alkaline phosphatase amylase anagrelide antihypertensive agent antilipemic agent asciminib aspartate aminotransferase BCR ABL protein bilirubin dasatinib hydroxyurea imatinib insulin nilotinib oral antidiabetic agent triacylglycerol lipase antineoplastic agent nicotinamide protein kinase inhibitor pyrazole derivative pyrimidine derivative abdominal pain add on therapy anemia arthralgia Article backache blast cell crisis cancer survival cerebrovascular accident cerebrovascular disease chronic myeloid leukemia controlled study cumulative incidence diabetes mellitus diarrhea drug dose increase drug efficacy drug withdrawal event free survival fatigue follow up headache human hypertension infection major clinical study monotherapy musculoskeletal disease nausea neutropenia pancreatitis phase 2 clinical trial progression free survival rash skin disease thrombocytopenia treatment failure treatment response upper respiratory tract infection clinical trial drug therapy genetics multicenter study myeloid leukemia very elderly | - |
| dc.title | Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study | - |
| dc.type | Journal Article | - |
| dc.description.affiliates | Haematology Department, Royal Adelaide Hospital, Adelaide Medical School, University of Adelaide and Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia The Alfred Hospital and Australian Centre for Blood Diseases, Monash University, Melbourne, Australia Department of Genetics and Molecular Pathology, SA Pathology and Centre for Cancer Biology, University of South Australia, and Adelaide Medical School, University of Adelaide, Adelaide, Australia Australasian Leukaemia and Lymphoma Group, Melbourne, Australia Haematology Department, Royal Perth Hospital and University of Western Australia, Perth, Australia Monash Haematology, Monash Health and Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre and Department of Medicine, University of Melbourne, Melbourne, Australia Haematology Department, Liverpool Hospital and University of New South Wales, Sydney, Australia Haematology Department, Concord Hospital and University of Sydney, Sydney, Australia Haematology Department, Flinders Medical Centre and Flinders University, Adelaide, Australia Haematology Department, Wellington Hospital and University of Otago, Wellington, New Zealand Haematology Department, Fiona Stanley Hospital and University of Western Australia, Perth, Australia Haematology Department, Royal Hobart Hospital and University of Tasmania, Hobart, Australia Haematology Department, Gosford Hospital, Gosford, Australia Haematology Department, St Vincent's Hospital and University of Melbourne, Melbourne, Australia Cancer Care Services, Royal Brisbane and Women's Hospital and University of Queensland, Brisbane, Australia Haematology Department, Auckland Hospital and University of Auckland, Auckland, New Zealand Haematology Department, Sir Charles Gardiner Hospital and PathWest, University of Western Australia, Perth, Australia Haematology Department, Austin Hospital and University of Melbourne, Melbourne, Australia | - |
| dc.identifier.doi | 10.1182/blood.2024024657 | - |
| dc.type.studyortrial | Article | - |
| dc.identifier.journaltitle | Blood | - |
| Appears in Collections: | Liverpool Hospital | |
Files in This Item:
There are no files associated with this item.
Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.
